Malaga Cove Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Malaga Cove Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$28.0 - $40.56 $159,376 - $230,867	5,692 New	5,692 $230,000
Q4 2021 Feb 10, 2022	SELL	$58.09 - $82.51 $64,596 - $91,751	-1,112 Reduced 15.92%	5,872 $389,000
Q3 2021 Nov 05, 2021	SELL	$58.38 - $84.96 $2,335 - $3,398	-40 Reduced 0.57%	6,984 $436,000
Q2 2021 Jul 27, 2021	SELL	$62.15 - $90.32 $21,690 - $31,521	-349 Reduced 4.73%	7,024 $582,000
Q3 2020 Nov 03, 2020	BUY	$33.21 - $51.27 $2,324 - $3,588	70 Added 0.96%	7,373 $317,000
Q2 2020 Jul 29, 2020	SELL	$26.12 - $43.27 $4,675 - $7,745	-179 Reduced 2.39%	7,303 $315,000
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $153,829 - $472,263	7,482 New	7,482 $210,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Malaga Cove Capital, LLC with notifications on news.